1. Home
  2. LPAA vs TCMD Comparison

LPAA vs TCMD Comparison

Compare LPAA & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPAA
  • TCMD
  • Stock Information
  • Founded
  • LPAA 2024
  • TCMD 1995
  • Country
  • LPAA United States
  • TCMD United States
  • Employees
  • LPAA N/A
  • TCMD N/A
  • Industry
  • LPAA
  • TCMD Medical/Dental Instruments
  • Sector
  • LPAA
  • TCMD Health Care
  • Exchange
  • LPAA Nasdaq
  • TCMD Nasdaq
  • Market Cap
  • LPAA 299.3M
  • TCMD 300.1M
  • IPO Year
  • LPAA 2024
  • TCMD 2016
  • Fundamental
  • Price
  • LPAA $10.52
  • TCMD $15.35
  • Analyst Decision
  • LPAA
  • TCMD Buy
  • Analyst Count
  • LPAA 0
  • TCMD 4
  • Target Price
  • LPAA N/A
  • TCMD $16.83
  • AVG Volume (30 Days)
  • LPAA 13.3K
  • TCMD 151.3K
  • Earning Date
  • LPAA 01-01-0001
  • TCMD 11-03-2025
  • Dividend Yield
  • LPAA N/A
  • TCMD N/A
  • EPS Growth
  • LPAA N/A
  • TCMD N/A
  • EPS
  • LPAA 0.35
  • TCMD 0.63
  • Revenue
  • LPAA N/A
  • TCMD $298,851,000.00
  • Revenue This Year
  • LPAA N/A
  • TCMD $8.65
  • Revenue Next Year
  • LPAA N/A
  • TCMD $8.66
  • P/E Ratio
  • LPAA $29.87
  • TCMD $24.55
  • Revenue Growth
  • LPAA N/A
  • TCMD 6.15
  • 52 Week Low
  • LPAA $9.97
  • TCMD $8.61
  • 52 Week High
  • LPAA $10.70
  • TCMD $21.10
  • Technical
  • Relative Strength Index (RSI)
  • LPAA 56.40
  • TCMD 68.81
  • Support Level
  • LPAA $10.50
  • TCMD $14.44
  • Resistance Level
  • LPAA $10.52
  • TCMD $14.79
  • Average True Range (ATR)
  • LPAA 0.01
  • TCMD 0.37
  • MACD
  • LPAA -0.00
  • TCMD 0.01
  • Stochastic Oscillator
  • LPAA 50.00
  • TCMD 93.75

About LPAA Launch One Acquisition Corp. Class A Ordinary shares

Launch One Acquisition Corp is a blank check company.

About TCMD Tactile Systems Technology Inc.

Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.

Share on Social Networks: